Howard,
Thank you very much for the information on your informal survey of Quidel's products. You're one of the first on this thread to report your observations.
Since you work at a hospital, you're in a very good position to learn about the market prospects for Quidel's products and how well they're selling.
Where did you check to find that Quidel's products are well accepted by the professional community? How did you conduct your informal survey to learn that Quidel's H.pylori test will be a big seller? Does your hospital have a pharmacy? Has the pharmacist noticed and increase in Quidel product sales? Has he spoken to a P&G rep recently? How do the doctors at your hospital test for strep, Chlamydia, or H.pylori? Do they use rapid tests?
With Quidel's 50 percent margin, increasing sales will have a big impact on Quidel's earnings. Day to day, week to week, month to month, Quidel's stock will fluctuate, but in the long run, Quidel's stock price will be based on its earnings. Quidel may be overlooked for now, but the market will not overlook Quidel's earnings increases for long, assuming they continue to increase, and I've got no reason to think they won't.
Again, thanks for the information.
Mike |
